FDA Announces Approval of Guidance for Formal Meetings Under Prescription Drug User Fee Act

Summary

The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) for a guidance document on formal meetings with sponsors and applicants for FDA-approved prescription drugs, as required by the Paperwork Reduction Act of 1995.